Skip to main content

Table 3 The subgroup of the relationship and heterogeneity between high SNHG12 expression and tumor stage

From: Long noncoding RNA SNHG12 is a potential diagnostic and prognostic biomarker in various tumors

Subgroup analysis

No. of studies

No. of patients

Pool OR (95% CI)

Weight

Heterogeneity random

Fixed

Random

I2 (%)

p value

ORs of tumor stage subgroup

9

639

3.94 [2.80, 5.53]

3.91 [2.77, 5.51]

100%

0

0.46

Cancer type

 Digestive system

4

222

4.54 [2.58, 8.00]

4.54 [2.58, 8.00]

36.60%

0

0.76

 Respiratory system

1

129

3.79 [1.75, 8.19]

3.79 [1.75, 8.19]

20.00%

-

-

 Reproductive system

2

178

2.24 [1.19, 4.21]

2.24 [1.19, 4.21]

29.70%

0

0.87

 Nervous system

1

79

8.79 [3.17, 24.32]

8.79 [3.17, 24.32]

11.40%

-

-

 Locomotor system

1

31

10.89 [1.14, 103.98]

10.89 [1.14, 103.98]

2.30%

-

-

Cut-off

 Others

3

 

3.59 [1.83, 7.02]

3.79 [1.58, 9.07]

25.00%

28.5

0.247

 Median

6

 

4.07 [2.74, 6.03]

4.06 [2.73, 6.05]

75.00%

0

0.445

Sample size

 Size < 60

4

235

3.76 [2.11, 6.69]

3.69 [2.05, 6.62]

34.70%

0

0.48

 Size ≥ 60

5

404

4.04 [2.65, 6.14]

4.07 [2.50, 6.65]

65.30%

23

0.46

Quality scores

 Score < 80

4

269

2.70 [1.60, 4.54]

2.62 [1.55, 4.44]

42.70%

0

0.6

 Score ≥ 80

5

370

5.25 [3.34, 8.26]

5.25 [3.33, 8.28]

57.30%

0

0.73